Molecular Targeting in Oncology (Cancer Drug Discovery and Development) - Image 1

£148.05

Humana Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Name: Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
Brand: Humana
Price: 146.98 GBP
Availability: InStock

Diseases & Disorders

This is the most expensive it has ever been. Walk away.

£148 today · previous high £148 · all-time low £147

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £148 (69 days, 76.7%)

Price range: £147 - £148

Price levels: 2 different prices over 90 days

Description

In Molecular Targeting in Oncology, authors present an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer and is structured in a way so readers may begin with chapters that most interest them and work through the rest of the chapters in the order of their choice. The volume is divided into five sections that cover the most important elements of drug development. The first section focuses on approaches using targeted therapies to inhibit cell growth. The second section describes how clinicians are evaluating targeted therapies in specific organ systems. The third section illustrates how various classes of pharmacologic and immunologic agents are developed for individual molecular targets. The fourth section details new drugs that have novel mechanisms of action. The final section looks to the future of targeted therapeutics and includes chapters on appropriate patient selection, use of combination therapy, dealing with tumor cell resistance, and more.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1617376531
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 26 May 2011
Listed Since: 11 July 2010

Barcode

No barcode data available

Humana Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)

Target Discovery and Validation Reviews and Protocols: Emerging Strategies for Targets and Biomarker Discovery, Volume 1: 360 (Methods in Molecular Biology)

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Integrin Targeting Systems for Tumor Diagnosis and Therapy (Methods in Pharmacology and Toxicology)

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)

Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Cancer-Targeted Drug Delivery (Methods in Pharmacology and Toxicology)

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)

Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)

Biopharmaceutical Drug Design and Development

Tumor Dormancy and Recurrence (Cancer Drug Discovery and Development)

Gene Regulation and Therapeutics for Cancer

Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)